Botanical species · safety record

Artemisia cina

The EFSA Compendium of Botanicals holds 6 constituent measurements for Artemisia cina. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Artemisia cina Berg ex Poljakov

6Constituent measurements

0Safety records

3Cited sources

12Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 12 licensed products naming Artemisia cina as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Capsule non épanoui, séché
Closed capitula/capitulum
Dried unopened flower heads
Flower head
Unexpanded flower heads
Unexpanded flower-heads
capitules non expanses de fleur

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Santonin	Leaves	Solvent extraction	0.83 Gram/100 gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Santonin	Leaves	Super-critical gas extraction	2.5 Gram/100 gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Artemisinin	Flower	Solvent extraction	0.13 Milligram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Artemisinin	Leaves	Solvent extraction	0.45 Milligram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Artemisinin	Roots and other underground parts	Solvent extraction	0.05 Milligram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Sesquiterpene lactones	Aerial part of plants	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Sakipova, Zuriyadda., Wong, Nikki Siu Hai., Bekezhanova, Tolkyn., Sadykova., Shukirbekova, Alma., Boylan, Fabio. Quantification of santonin in eight species of Artemisia from Kazakhstan by means of HPLC-UV: Method development and validation . Plos one, 2017, vol. 12, no. 3. DOI
Aryanti., Yuniawati, Marina. MUTATION INDUCTION FOR IMPROVING OF ARTEMISININ CONTENT IN EACH PART OF ARTEMISIA CINA MUTAN LINES . Indonesian journal of pharmacy, 2015, vol. 26, no. 3, p. 158-165.
Seo, Ean-Jeong., Saeed, Mohamed., Law, Betty Yuen Kwan., Wu, An Guo., Kadioglu, Onat., Greten, Henry Johannes., Efferth, Thomas. Pharmacogenomics of scopoletin in tumor cells. Molecules, 2016, vol. 21, no. 4, p. 496/1-496/23.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature